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1. Introduction
From the economically point of view, vine (Vitis spp.) is 
one of the most important plant species due to the produc-
tion of wine, juice and other grape-derived products [1]. 
The grape berry is characterized by the presence of differ-
ent classes of phytochemicals, which have been investi-
gated for their health promoting properties. To date, more 
than 500 compounds have been identified in Vitis vinifera 
fruit and derivatives. The positive effects on human health 
are normally associated with the phenolic compounds [2]; 
most of them are flavonoids, classified as flavanols, fla-
vonols and anthocyanins. Grape skins of red varieties and 
leaves contain mainly anthocyanins and flavonols. The 
most important anthocyanins are the 3-O-monoglucoside 
and the 3-O-acylated monoglucosides of delphinidin, 
cyanidin, petunidin, peonidin and malvidin. The most 
abundant flavonols are the 3-O-glycosides of myricetin, 
quercetin, kaempferol and isorhamnetin. Grape seeds, skin 
and stems are also important sources of proanthocyanidins 
(PROs), oligomers and polymers of (+)-catechin, (–)-epi-
catechin, and (–)-epicatechin gallate. In addition, skin and 
stems contain prodelphinidins, oligomers and polymers 
of (–)-epigallocatechin and trace amounts of (+)-gallocat-
echin and (–)-epigallocatechin gallate [2]. The beneficial 
effects of grape flavonoids have been widely studied since 
their association with the so-called “French Paradox” [3]. 
The term refers to the epidemiological observation of 
comparatively low incidence of coronary heart disease in 
the population of some Mediterranean regions, despite the 
presence of a local diet rich in saturated fats. The tradi-
tion of regular and moderate consumption of red wine was 
hypothesized as the main factor responsible for decreas-
ing the risk for cardiovascular diseases [4]. On the other 
hand, the wine market has shown a decreasing trend due 
to the frequent abuse/misuse of alcoholic beverages also in 
young people; this social problem was faced in December 
2009 by WHO with the paper “Strategies to reduce the 
harmful use of alcohol: draft global strategy” [5]. This 
social situation has stimulated the scientific research in the 
field of grape and its non-alcoholic derivatives (such as 
grape juices, extracts and raisins), which could be suitable 
alternative sources of healthy molecules. It has been sug-
gested that the reduction of death from all causes, observed 
with moderate wine consumption, could be reproduced 
with the introduction in the diet of certain fruits, grains 
and vegetables, having similar content of phenolic com-
pounds. Also OIV, in its strategic plan 2015–2019, under-
lines the importance of “evaluating, in collaboration with 
the FAO and the WHO, the health aspects, nutritional 
potential and socio-behavioural factors of all non-alco-
holic vine derived products”. On this basis, the aim of this 
work is to provide a preliminary review on the different 
healthy effects associated with non-alcoholic grape prod-
ucts including table grapes, grape juice, raisins and seed/
skin extracts.
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2. Methods
PubMed/MEDLINE and Embase were systematically 
searched to create the present work. These databases are 
among the most important and comprehensive scientific 
tools for references/abstracts on life sciences and bio-
medical topics. The following search strategy and selec-
tion criteria were used: data were collected from database 
inception to April 2015, with the terms “grape”, “raisins”, 
“grape extract”, “grape juice”, in combination with “ben-
efits” or “health”. Using this search method, the main 
health-related effects, associated with grape derivative con-
sumption, were easily identified. Some search limits were 
established and, for this paper, only studies performed in 
humans were collected and discussed. All classes of human 
intervention trials were selected, although randomized, 
placebo-controlled studies were considered to provide the 
most reliable evidences.
3. Results and discussion
The search by title and abstract allowed the collection of 
518 publications. By removing the duplicates and the not 
pertinent papers, the final number of publications included 
was 56. Positive effects due to the consumption of grape 
and derivatives (apart from wine) were evidenced in the 
following areas: cardiovascular function (including oxi-
dative stress, inflammation and metabolic syndrome), 
inflammation, immune function, diabetes, oral health, 
cancer, and cognitive function. The number of studies 
collected in each health area is listed in Table 1. Selected 
studies considered grape, juices, grape seed/skin extracts 
and raisins. Since the number of studies collected is very 
high, this paper will list only the number of citations sup-
porting or not supporting a certain biological event. The 
most recent references will be cited, and will refer both 
to positive and negative results. A more comprehensive 
review will be prepared and sent for publication in a peer-
reviewed journal.
all racial and ethnic groups. Epidemiological and experi-
mental evidences suggest a protective effect on cardiovas-
cular diseases and stroke of a diet containing foods, rich 
in polyphenols [6]. As reported in Table 2, most studies 
investigating the effects of grape juice and grape extracts 
measured urinary isoprostanes, total and LDL choles-
terolemia, LDL oxidation, endothelial function, platelet 
aggregation and inflammatory cytokine levels, which are 
among the most widely recognized biomarkers for cardio-
vascular diseases [7,8]. The most important positive effects 
reported were: 1) the reduction of systolic blood pressure 
(5 papers with positive association and one with no sig-
nificant difference versus control) [9–11]; 2) the improve-
ment of endothelial functions, assessed by measuring the 
flow-mediated- dilatation (FMD) of the brachial artery 
(11 in favour and 3 without significant results) [9,12–14]. 
Encouraging results were observed on systolic blood pres-
sure; in fact 5 papers out of 6 indicated a reduction of this 
parameter in both healthy and pre-hypertensive subjects 
after the consumption of one cup daily (for 42 days) of 
raisins or a snack containing raisins 3 times a day (for 
84 days) [15,16].
In particular, a supplementation of purple grape juice 
(640 or 320 mL/day for 28 days), in adults with severe 
endothelial dysfunction, significantly increased the FMD 
of the brachial artery from 1.3 ± 2.3 to 2.9 ± 3.9% [17]. 
A similar effect on FMD was observed in adolescents 
affected by metabolic syndrome [12] and in adults with 
coronary artery disease [19]. The investigators suggested 
that the observed effects were due to the enhancement 
in the nitric oxide (NO) bioactivity, responsible for the 
positive modulation of endothelial function. Controversial 
results were observed on the improvement of plasma cho-
lesterol profile (reduction of LDL-cholesterol mediated 
by an increased expression of LDL receptors) after the 
intake of grape derivatives (4 studies in favour and 4 with-
out significant difference) [13,15,19,20], while significant 
Table 1. Number of the studies involving non-alcoholic grape 
products and health areas investigated.
Grape juice 
and grape
Grape 
extracts Raisins
Cardiovascular 
function 14 15 2
Diabetes 2 1 3
Inflammation and 
immune function 2 6 1
Cognitive function 3 – –
Cancer 2 3 –
Oral health – 1 1
Total papers 23 26 7
Table 2. Studies assessing the effects of unfermented grape 
derivatives on parameters associated with CV diseases.
Parameter
Papers 
with positive 
effects
Papers with 
no significant 
difference
Ref.
Endothelial 
function as FMD
11 
(GJ, GE)
3
(GJ, GSE)
9,
12-14
Inflammatory 
biomarkers
6
(GJ, GE, R)
7  
(GJ, GE)
15,19
21,24
Oxidative stress
(LDL-oxidation)
8
(GJ, GE, R)
4
(GJ, GE)
13,
20-22
Blood lipids 
(LDL-CHO, 
triglycerides)
4
(GJ, GE, R)
4  
(G/GSE, R)
13,15
19-20
Blood pressure 
reduction
5
(GJ, G/GSE, R)
1  
(GSE) 9-11
Platelet 
aggregation
1
(GJ)
4  
(GJ) 23-26
G: Grape; GE: Grape Extract; GSE: grape seed extract; R: raisins; CHO: cholesterol; 
FMD: flow-mediated-dilatation.
3.1. Cardiovascular (CV) function
Cardiovascular disease is the leading cause of death in the 
United States and Europe for both men and women among 
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results were reported on LDL-oxidation (8 studies versus 
4) [13,20–22]. Few studies, enrolling healthy subjects, 
evaluated the effects of grape juice on platelet aggrega-
tion; the results on this effect are not sufficiently supported 
(1 paper in favour and 4 without significant difference) 
[23–26].
Generally speaking, controversial results have been 
obtained on the reduction of inflammatory parameters 
associated with cardiovascular diseases after supplemen-
tation with grape juice and extracts. For example, Albers 
et al. (2004) [25] showed a significant reduction of soluble 
CD40 ligand (sCD40L) in 20 subjects affected by coronary 
diseases after consumption of purple grape juice (490 mL/
day for 14 days). A significant reduction of the inflam-
matory markers sICAM-1 (soluble intercellular adhesion 
molecule) was measured in subjects affected by metabolic 
syndrome after the consumption of 46 g/day of a food sup-
plement containing grape seed extract (corresponding to 
2 servings/day of fresh grapes) [9]. Other papers did not 
find any significant difference versus control groups (see 
Table 2).
3.2. Diabetes/obesity
Type 2 diabetes is a chronic disease characterized by hyper-
glycaemia, peripheral resistance to the action of insulin, 
and a reduced activity of insulin-producing β-cells in the 
pancreas. Obesity is among the most important risk fac-
tors for diabetes. Other risk factors include family history, 
physical inactivity, hypercholesterolemia, hypertriglyc-
eridemia, and hypertension. Results from epidemiologi-
cal studies on the relationship between dietary flavonoids 
and development of type 2 diabetes are controversial [27]. 
In addition, only few human studies have considered the 
effects of grape derivatives, apart from wine, on metabolic 
parameters associated with diabetes (Table 3). Since the 
Glycemic Index (GI) of grape falls within the low range, 
this fruit is considered appropriate for inclusion in a diet 
targeting low glycemic foods, like that for diabetic indi-
viduals [28].
Banini et al. [29] investigated in 29 subjects affected 
by type 2 diabetes the effects of the consumption of 
150 mL/day of grape juice, wine and dealcoholized wine 
from Vitis rotundifolia (muscadine). Fasting blood glucose 
levels, insulin response and the concentration of glycated 
haemoglobin were measured. Subjects receiving the deal-
coholized wine for 28 days showed reduced fasting blood 
insulin levels compared to other groups. In addition, the 
blood glucose/insulin ratio in fasting condition increased 
from 8.5 to 13.1 during the 28-day intervention study. This 
effect was considered positive, since a glucose/insulin 
ratio <7 is predictive of insulin resistance. No difference 
in fasting blood glucose, insulin, or glycated haemoglobin 
levels was observed before and after the intervention study 
in groups consuming muscadine grape juice or wine [29].
These preliminary positive results could be due to 
those polyphenols, found in grapes or vine-derived prod-
ucts, which have shown inhibitory effects in animal mod-
els, where diabetes was chemically induced. Furthermore, 
some authors showed that the grape procyanidins increased 
the uptake of glucose in adipocyte cell lines, where procy-
anidins could have an insulin mimetic effect [34].
In a study involving 38 overweight/obese and first-
degree relatives of type 2 diabetic patients, an increase of 
hepatic insulin sensitivity and a reduction of the oxidative 
stress were shown after a supplementation with 2 g/day of 
a red grape extract in comparison with subjects receiving 
placebo [32]. The positive effects of grapes on oxidative 
stress is supported by in vitro studies, where proanthocy-
anidins and resveratrol decreased lipid peroxidation and 
increased pancreatic glutathione levels [35]. These data, if 
confirmed by human studies, indicate that the grape seed 
proanthocyanidins can protect β-cell function and suggest 
a protective effect against generation of damaging reactive 
oxygen species.
Raisins, like other dried fruits, have been generally 
considered unsuitable in the diet of obese and diabetic 
subjects due to the high sugar content and the energy con-
tribution. As a consequence, the insulin response to raisins 
has been evaluated only in few studies. This parameter 
was evaluated in 1) sedentary adults; 2) prediabetic indi-
viduals; and 3) aerobically trained subjects by Kim et al. in 
2008 [34]. In all subjects, the GI after raisins consumption 
was approximately 50 with no difference between groups 
(each group n = 10); in addition, the serum insulin AUC 
(Area Under the Curve) in response to the intake of 69 g 
raisins was lower if compared with glucose. The glycae-
mic and insulin index were higher in endurance athletes 
(62 ± 5 and 57 ± 7, respectively), but the difference with 
the other groups was not statistically significant. In a study 
by Bays et al. (2012) performed in 46 healthy subjects, 
the consumption of a snack containing raisins, three times/
day, determined a significant reduction of postprandial 
glycaemia (16%) [16]. Among the positive effects for dia-
betic subjects associated with the consumption of raisins, 
there is the promotion of satiety by affecting the levels 
of hormones involved in the regulation of appetite [36]. 
Moreover, cumulative energy intake (calculated as total 
kcal introduced) was lower in the groups taking water or 
the raisins snack versus those consuming grape or other 
usual snacks, such as chocolate cookies or potato chips 
(p < 0.031) [33]. Despite the promising results, consider-
ing the paucity of data available, further studies are needed 
Table 3. Studies assessing the effects of unfermented grape 
derivatives on parameters associated to diabetes.
Parameter
Papers 
supporting 
a positive 
effect
Papers 
with no 
significant 
difference
Ref.
Insulin response 4
(GJ, GE)
1  
(R) 29–32
Fasting and post- 
prandial glycaemia
2  
(GJ, R)
1  
(GJ) 16,29,31
Glycated 
haemoglobin
1  
(GJ)
1  
(R) 16,29
Reduction of food 
intake
1  
(R)
1  
(GJ) 31,33
Modulation body 
weight –
1  
(GJ) 32
Oxidative stress 1  
(GE) – 32
Abbreviations as in Table 2.
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to investigate the potential health benefits of grape and 
derivatives in this area.
3.3. Neurocognitive function
The number of subjects suffering from dementia world-
wide is currently estimated in more than 35 million and 
is projected to reach more than 81 million cases by the 
year 2040 [37]. Mild cognitive impairment represents an 
important risk factor for dementia, and progression from 
mild cognitive impairment to Alzheimer’s disease can be 
as high as 10% per year [38].
The regulation of inflammatory processes, often 
decreased with ageing, is associated with an acceleration 
of neurodegenerative disorders. In in vitro studies berry 
fruits (including grape) containing a good polyphenol pro-
file have shown anti-inflammatory and antioxidant prop-
erties, which could support neuroprotective effects [39]. 
To date, these positive effects on human health have been 
rarely investigated (Table 4).
Only two studies, conducted by Krikorian et al. (2010 
and 2012) evaluated the effects of the supplementation of 
concord grape juice on cognitive function in older adults 
with cognitive impairment [40,41]. In both studies partici-
pants with forgetfulness and prospective memory lapses 
received Concord grape juice for 12 and 16 weeks, respec-
tively. In the first study a significant improvement in a 
measure of verbal learning (P = 0.04), but not of verbal 
and spatial recall, was observed in those subjects receiving 
concord grape juice. In the study performed by the same 
authors in 2012, a significant improvement of memory was 
observed after concord grape juice intake for 16 weeks and 
this effect was scientifically supported by the grater acti-
vation in anterior and posterior regions of the right hemi-
sphere measured by magnetic resonance imaging [41]. In 
order to explain the results obtained, authors speculated 
that anthocyanins could be involved in the reduction of 
oxidative stress and inflammatory markers in brain tissues.
Another study was performed in 20 healthy young 
adults, who received in single dose 200 mL of Concorde 
purple grape juice or placebo (sugar and flavour) [42]. 
After 30 min from intake, a significant increase of calme 
ratings (p < 0.05) and an improvement in speed of atten-
tion (p < 0.05) were observed. No effect on memory was 
registered.
3.4. Cancer
As shown in Table 5, few papers in humans (with con-
troversial results) have been published on the relationship 
between unfermented grape derivatives and prevalence of 
cancer, apart from epidemiological studies showing a pro-
tective property of a diet rich in fruits and vegetables [43].
Brooker et al. (2006) investigated whether a grape seed 
extract was effective, compared to placebo, in reducing 
tissue induration after high-dose radiotherapy in sixty-six 
women with early breast cancer [44]. After 12 months, no 
significant difference was recorded between treatment and 
control groups in terms of external assessment of tissue 
hardness, breast appearance or patient self-assessment of 
breast hardness.
Chen et al. (2014) measured the colorectal cancer 
progression in patients receiving the antitumoral 5-fluoro-
uracil with or without a food supplement containing veg-
etable derivatives, including grape seed extract [45]. No 
significant difference was observed in overall response 
rate and overall survival, but patients receiving the food 
supplement had a significant reduction of disease pro-
gression rate. A study was performed in 67 healthy adults 
(16 women and 51 men) to evaluate if a daily regimen 
of grape juice consumption (480 mL/day for 8 weeks) 
Table 4. Studies assessing the effects of unfermented grape 
derivatives on cognitive function.
Parameter
Papers 
supporting 
a positive 
effect
Papers 
with no 
significant 
difference
Ref.
Verbal learning in old 
adults with cognitive 
impairment
1  
(GJ) – 40
Verbal and spatial 
recall in old adults with 
cognitive impairment
–
1  
(GJ) 40
Memory improvement 
in old adults with 
cognitive impairment
1  
(GJ) – 41
Calme rating and speed 
attention in young 
subjects
1  
(GJ) 42
Memory in young 
subjects
1  
(GJ) 42
Abbreviations as in Table 2.
Table 5. Studies assessing the effects of unfermented grape 
derivatives on cancer.
Parameter
Papers 
supporting 
a positive 
effect
Papers 
with no 
significant 
difference
Ref.
Tissue induration after 
radiotherapy in women 
with early breast cancer
1  
(GSE) 44
Overall response rate 
of colorectal cancer 
progression in patients 
receiving the antitumoral 
5-fluoro- uracil
–
1  
(GSE^) 45
Reduction of disease 
progression rate in the 
group of patient above
1  
(GSE) - 45
Reduction of DNA 
damage in peripheral 
lymphocytes and ROS 
release
1  
(GJ) - 46
Reduction of breast 
cancer risk in pre- and 
post-menopausal women
1  
(G) - 47
Abbreviations as in Table 2.
^ Mixture of vegetable extracts, including GSE.
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reduced the DNA damage in peripheral lymphocytes and 
the amount of free endogenous reactive oxygen species 
(ROS) released [46]. Grape juice consumption determined 
a significant decrease of DNA damage before and after 
the period of supplementation. Moreover a reduction by 
15% was observed in free radical release, compared to 
the beginning of the supplementation. These findings sup-
ported a possible cancer-protective property of grape juice 
on lymphocytes, due to the reduced release of ROS.
A study by Do et al. [47] examined the relationship 
between fruit and vegetable consumption on breast can-
cer risk in pre- and post-menopausal Korean women. High 
grape intake demonstrated an inverse association on breast 
cancer incidence in post-menopausal women (OR = 0.59).
3.5. Inflammation and immune system
Inflammation is the first body’s response to infection or 
injury, and a critical process for both innate and adap-
tive immunity. It can be considered as part of the com-
plex biological response of vascular tissues to harmful 
stimuli, such as pathogens, damaged cells, or irritants. 
Uncontrolled inflammation often results in chronic dis-
eases, such as arthritis, autoimmune disorders, degenera-
tive joint diseases, rheumatisms, atherosclerosis, diabetes 
and even cancer.
Several mediators participate to the inflammatory 
process; some are released in the first steps (i.e. his-
tamine, serotonin, etc.), others are synthesized and 
released within a short time (prostaglandins, leukot-
rienes, platelet-activating factor, etc.), others require a 
de novo synthesis (cytokines, adhesion molecules, etc.). 
Several cytokines cooperate to induce the gene expres-
sion of specific promoters. The induction of most among 
these genes is dependent on the presence of binding sites 
for the nuclear factor kB (NF-kB), which regulates genes 
involved in many aspects of the inflammatory response 
[48]. In response to a variety of pro-inflammatory stimuli, 
such as cytokines or oxidative stress, NF-kB transcrip-
tion factor induces pro-inflammatory genes encoding 
for the synthesis of cytokines, chemokines, adhesion 
molecules, such as intercellular adhesion molecules-1 
(ICAM-1), E selectin, cyclooxygenase-1 (COX-1) and 2, 
inducible nitric oxide synthase (iNOS) and metallopro-
teases (MMP).
Little research has been performed to evaluate the anti-
inflammatory effects of unfermented grape products. A 
recent review [49] has summarized the results obtained in 
human intervention trials and in epidemiological studies, 
which evaluated the effects of unfermented grape deriva-
tives in different pathological conditions and in healthy 
subjects. Table 6 lists the studies on the effects of differ-
ent grape derivatives in healthy subjects and in systemic 
sclerosis. Positive preliminary results have been obtained 
in the reduction of biomarkers of oxidative stress (e.g. 
glutathione peroxidase levels and malondialdehyde-mod-
ified LDL) and inflammation (E-selectin and ICAM-1) 
after consuming grape seed extracts by healthy subjects 
and patients affected by systemic sclerosis [50–54]. Even 
though, the available data are promising, new studies are 
necessary to confirm the positive results.
Two studies reported positive results on the immune 
system when middle-aged and aged subjects consumed 
Concord grape juice for 9–10 weeks. When compared to 
placebo, an increase of T-cell proliferation and a higher 
serum vitamin C level were observed [55].
Moreover, Zunino et al. [19] measured the T-cell 
cytochine production in obese subjects after the consump-
tion of grape extract for 21 days. No significant difference 
was observed compared to control group.
3.6. Oral health
Some data on other research areas have been published 
and collected for this preliminary review. In particular, 
the effects of non–alcoholic grape derived products were 
investigated in oral health.
Surprisingly, some positive results were obtained 
when the effects of raisins were evaluated in oral health. 
In fact, raisins are generally considered cariogenic for 
their stickiness and acidogenicity [57]. However, when 
the effect of raisins and raisin-containing bran cereal on 
plaque acidogenicity was examined in 7- to 11-year-old 
children, it was observed that raisins did not reduce the 
teeth plaque pH below 6 over the 30-min test period. If 
confirmed by further studies, these data could support rai-
sins as a healthy alternative to the commonly consumed 
sweet snack foods [58].
In vitro studies showed that also grape seed extracts, 
which contain high amount of proanthocyanidins, posi-
tively affected the demineralization and/or remineraliza-
tion processes of artificial root caries lesions, suggesting 
their use as promising natural agents for noninvasive root 
caries prevention [59,60].
Table 6. Studies assessing the effects of unfermented grape 
derivatives on inflammation and immune system.
Parameter
Papers 
supporting 
a positive 
effect
Papers 
with no 
significant 
difference
Ref.
Reduction of oxidative 
stress in healthy subjects 
(production of MDA)
2  
(GSE)
1  
(GSKE)
50
53-54
Reduction of oxidative 
stress in healthy subjects 
(glutathione peroxidase 
activity)
1  
(GSE) – 53
Reduction of 
inflammation in systemic 
sclerosis (reduction of 
E- selectin)
1  
(GSE) – 50
Reduction of 
inflammation in systemic 
sclerosis (reduction of 
ICAM-1)
1  
(GSE) – 50
T-cell proliferation 2  
(GJ) – 56
Level of T-cell 
cytochines -
1  
(GE) 19
GSKE: grape skin extract; MDA: malondialdehyde; ICAM-1: intercellular adhesion 
molecule-1. Other abbreviation as in Table 2.
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4. Conclusion
The results presented in this review underline some well-
established beneficial effects of unfermented grape prod-
ucts on cardiovascular health, such as the improvement 
of endothelial function and a reduction of LDL oxidation, 
factors which have been associated with the atherosclero-
sis process progression. Despite the paucity of data about 
raisins, promising results have been obtained in cardiovas-
cular area, thanks to the observed reduction of oxidative 
stress and blood pressure.
Some papers reported the positive effects of grape 
products in diabetes; in fact grape juice, grape extracts and 
raisins seemed responsible for beneficial effects mediated 
by an increased hepatic insulin sensitivity and reduced 
plasmatic postprandial glycaemia. Raisins, included 
in some studies in form of snack, showed to be useful 
in reducing appetite and the total meal-energy intake in 
children. Other promising areas of research, where unfer-
mented grape products have shown preliminary positive 
results, are related to the neurocognitive function, immune 
system and oral health.
Generally speaking, some limitations and critical points 
were identified in all studies reviewed. Among them: 1) 
diet and lifestyle modifications during intervention were 
not always detailed; 2) differences in background diets 
between intervention and control groups were scarcely 
considered although strongly associated with the changes 
in biological markers during intervention; 3) a very small 
number of participants was enrolled in the majority of the 
trials collected; 4) polyphenol content and phytochemical 
characterization of the grape products, used in the studies, 
were rarely detailed. Further studies in humans, including 
a more suitable number of subjects, are required to con-
firm the findings showed in this review and to investigate 
in humans other positive effects, which are only specula-
tively supported by in in vitro or in animal models.
Chiara Di Lorenzo thanks OIV for the research grant, which sup-
ported partially this study.
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